Contribution of K<sub>V</sub>1.5 Channel to Hydrogen Peroxide-Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27872049.
- Also identified by DOI 10.1161/CIRCRESAHA.116.309491 and PMC identifier 5315616.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) regulates vascular tone in the human microcirculation under physiological and pathophysiological conditions. It dilates arterioles by activating large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels in subjects with coronary artery disease (CAD), but its mechanisms of action in subjects without CAD (non-CAD) when compared with those with CAD remain unknown. We hypothesize that H<sub>2</sub>O<sub>2</sub>-elicited dilation involves different K<sup>+</sup> channels in non-CAD versus CAD, resulting in an altered capacity for vasodilation during disease. H<sub>2</sub>O<sub>2</sub> induced endothelium-independent vasodilation in non-CAD adipose arterioles, which was reduced by paxilline, a large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel blocker, and by 4-aminopyridine, a voltage-gated K<sup>+</sup> (K<sub>V</sub>) channel blocker. Assays of mRNA transcripts, protein expression, and subcellular localization revealed that K<sub>V</sub>1.5 is the major K<sub>V</sub>1 channel expressed in vascular smooth muscle cells and is abundantly localized on the plasma membrane. The selective K<sub>V</sub>1.5 blocker diphenylphosphine oxide-1 and the K<sub>V</sub>1.3/1.5 blocker 5-(4-phenylbutoxy)psoralen reduced H<sub>2</sub>O<sub>2</sub>-elicited dilation to a similar extent as 4-aminopyridine, but the selective K<sub>V</sub>1.3 blocker phenoxyalkoxypsoralen-1 was without effect. In arterioles from CAD subjects, H<sub>2</sub>O<sub>2</sub>-induced dilation was significantly reduced, and this dilation was inhibited by paxilline but not by 4-aminopyridine, diphenylphosphine oxide-1, or 5-(4-phenylbutoxy)psoralen. K<sub>V</sub>1.5 cell membrane localization and diphenylphosphine oxide-1-sensitive K<sup>+</sup> currents were markedly reduced in isolated vascular smooth muscle cells from CAD arterioles, although mRNA or total cellular protein expression was largely unchanged. In human arterioles, H<sub>2</sub>O<sub>2</sub>-induced dilation is impaired in CAD, which is associated with a transition from a combined large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup>- and K<sub>V</sub> (K<sub>V</sub>1.5)-mediated vasodilation toward a large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup>-predominant mechanism of dilation. Loss of K<sub>V</sub>1.5 vasomotor function may play an important role in microvascular dysfunction in CAD or other vascular diseases.
Medical subject headings
- Arterioles
- Coronary Artery Disease
- Hydrogen Peroxide
- Kv1.5 Potassium Channel
- Vasodilation